Entering text into the input field will update the search result below

Aeglea BioTherapeutics appoints Linda Neuman as chief medical officer

  • Aeglea BioTherapeutics (NASDAQ:AGLE) said on Tuesday it had appointed Linda Neuman as the chief medical officer.
  • Neuman's appointment is an internal promotion from her previous role as Aeglea's senior vice president of clinical development.
  • Before Aeglea, Neuman served as vice president, clinical development at Catalyst Biosciences where she led the clinical development of their late-stage development program for a novel hemophilia treatment.

Recommended For You

More Trending News

About SYRE Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SYRE--
Spyre Therapeutics, Inc.